Home
About Us
Management
Technology & Products
Electroceuticals®
EFFECT Trial
SofPulse® Electroceutical® Therapy
Scientific Studies
Patents
Investors
Overview
Regulation A Offering
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
Contact
Home
About Us
Management
Technology & Products
Electroceuticals®
EFFECT Trial
SofPulse® Electroceutical® Therapy
Scientific Studies
Patents
Investors
Overview
Regulation A Offering
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
Contact
Management
Kodenbushi
Investors
Overview
Regulation A Offering
Regulation A Offering
News / Events
Press Releases
Email Alerts
Company Information
Profile
Management Team
Scientific Advisory Board
Presentations
IR Contacts
FAQ
Financial Information
Quarterly Results
Stock Data
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Board of Directors
Email Alerts
Presentations
Tear Sheet
IR Contacts
RSS News Feed
Press Releases
All News
By Year:
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Feb 24, 2020 • 1:00 PM EST
Endonovo Therapeutics Introduces Support of SofPulse® With A New Ancillary Multi-Use Patient Brace From Protex
Feb 20, 2020 • 11:00 AM EST
Endonovo Therapeutics Begins Process For Medical Reimbursements
Feb 13, 2020 • 7:30 AM EST
Endonovo Therapeutics Announces collaborating with a Stanford University sponsored Orthopedic Shoulder and Knee Study
Feb 10, 2020 • 7:30 AM EST
Endonovo Therapeutics announces its collaboration with Major Universities for the Evaluation of SofPulse® for Orthopedic Surgeries
Feb 4, 2020 • 7:30 AM EST
Endonovo Therapeutics Reduces Debt
Jan 30, 2020 • 7:00 AM EST
Endonovo Therapeutics Expands SofPulse® Sales to Plastic Surgery Centers
Jan 27, 2020 • 7:00 AM EST
Endonovo Therapeutics Announces First SofPulse® Sales to a Veterans Medical Center
Jan 14, 2020 • 9:00 AM EST
Endonovo Therapeutics Announces Issuance of Broad Patent Covering Electromagnetic Treatment of Multiple Sclerosis
Jan 7, 2020 • 8:30 AM EST
Endonovo Therapeutics Announces Issuance of U.S. Patent Covering Apparatus and Method for Electromagnetic Treatment of Neurological Injury or Condition Caused by a Stroke
Dec 23, 2019 • 8:30 AM EST
Endonovo Therapeutics Provides SofPulse® To All NFL Teams
<< Previous
1
2
3
4
5
6
7
8
9
10
...13
Next >>
Show All